Cyclosporin A treatment failed to extend skin allograft survival in two burn patients.
Prolongation of skin allograft survival by immunosuppression of burn casualties has been reported sporadically during the past two decades. Recently cyclosporin A (CycA) has been used effectively for such an indication. We report here two paediatric patients with extensive burns (85-95 per cent BSA) treated with fresh, family-related skin allografts that were rejected during CycA treatment after 14-18 days. One of these children survived while the other died with candida sepsis.
Eldad
A
A
Burn Unit, Hadassah University Hospital, Ein Kerem, Jerusalem, Israel.
Benmeir
P
P
Weinberg
A
A
Neuman
A
A
Chaouat
M
M
Ben-Bassat
H
H
Wexler
M R
MR
D002056:Burns / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use*; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D008297:Male; D016038:Skin Transplantation; D014184:Transplantation, Homologous
D016572:Cyclosporine